Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Aug 1;341(Pt 3):853–859.

Characterization of homogeneous recombinant rat ovarian 20alpha-hydroxysteroid dehydrogenase: fluorescent properties and inhibition profile.

H Ma 1, T M Penning 1
PMCID: PMC1220427  PMID: 10417353

Abstract

In rat ovary, 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD), a member of the aldo-keto reductase (AKR) superfamily, converts progesterone into the inactive progestin 20alpha-hydroxyprogesterone and has been implicated in the termination of pregnancy. Here we report a convenient overexpression system that permits the purification of milligram quantities of homogeneous recombinant 20alpha-HSD with wild-type enzyme activity. The availability of this enzyme has permitted detailed kinetic, inhibition and fluorescence analyses. The enzyme exhibited narrow steroid specificity, catalysing reactions only at C-20; it reduced progesterone and 17alpha-hydroxyprogesterone and oxidized 20alpha-hydroxypregnanes. It also turned over common AKR substrates, such as 9, 10-phenanthrenequinone and 4-nitrobenzaldehyde. The intrinsic fluorescence spectrum of 20alpha-HSD was characterized and was quenched on the binding of NADP(H), yielding a KNADPd of 0.36 microM and a KNADPHd of 0.64 microM. NADP(H) binding generated an energy transfer band that could not be quenched by steroids. Inhibition studies conducted with non-steroidal and steroidal anti-inflammatory drugs and synthetic oestrogens indicated that even though rat ovarian 20alpha-HSD and rat liver 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD) share more than 67% amino acid identity, their inhibition profiles are markedly different. Unlike 3alpha-HSD, most of these compounds did not inhibit 20alpha-HSD. Only meclofenamic acid and hexoestrol were potent competitive inhibitors for 20alpha-HSD, yielding K(i) values of 18.9 and 14.3 microM respectively. These studies suggest that selective non-steroidal AKR inhibitors could be developed for 20alpha-HSD that might be useful in maintaining pregnancy and that specific inhibitors might be developed from either N-phenylanthranilates or biphenols.

Full Text

The Full Text of this article is available as a PDF (173.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett M. J., Albert R. H., Jez J. M., Ma H., Penning T. M., Lewis M. Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. Structure. 1997 Jun 15;5(6):799–812. doi: 10.1016/s0969-2126(97)00234-7. [DOI] [PubMed] [Google Scholar]
  2. Diaz-Zagoya J. C., Wiest W. G., Arias F. 20 alpha-Hydroxysteroid oxidoreductase activity and 20 alpha-dihydroprogesterone concentration in human placenta before and after parturition. Am J Obstet Gynecol. 1979 Mar 15;133(6):673–676. doi: 10.1016/0002-9378(79)90017-6. [DOI] [PubMed] [Google Scholar]
  3. Diaz-Zagoya J. C., Wiest W. G., Arias F. Metabolism of progesterone by placentas from several mammalian species in vitro. Am J Obstet Gynecol. 1979 Nov 15;135(6):809–813. doi: 10.1016/0002-9378(79)90396-x. [DOI] [PubMed] [Google Scholar]
  4. Horwitz K. B., Wei L. L., Sedlacek S. M., d'Arville C. N. Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog Horm Res. 1985;41:249–316. doi: 10.1016/b978-0-12-571141-8.50010-x. [DOI] [PubMed] [Google Scholar]
  5. Hoyer P. B. Regulation of luteal regression: the ewe as a model. J Soc Gynecol Investig. 1998 Mar-Apr;5(2):49–57. doi: 10.1016/S1071-5576(97)00105-6. [DOI] [PubMed] [Google Scholar]
  6. Jez J. M., Bennett M. J., Schlegel B. P., Lewis M., Penning T. M. Comparative anatomy of the aldo-keto reductase superfamily. Biochem J. 1997 Sep 15;326(Pt 3):625–636. doi: 10.1042/bj3260625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jez J. M., Flynn T. G., Penning T. M. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol. 1997 Sep 15;54(6):639–647. doi: 10.1016/s0006-2952(97)84253-0. [DOI] [PubMed] [Google Scholar]
  8. Jez J. M., Schlegel B. P., Penning T. M. Characterization of the substrate binding site in rat liver 3alpha-hydroxysteroid/dihydrodiol dehydrogenase. The roles of tryptophans in ligand binding and protein fluorescence. J Biol Chem. 1996 Nov 22;271(47):30190–30198. doi: 10.1074/jbc.271.47.30190. [DOI] [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Majewska M. D., Harrison N. L., Schwartz R. D., Barker J. L., Paul S. M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986 May 23;232(4753):1004–1007. doi: 10.1126/science.2422758. [DOI] [PubMed] [Google Scholar]
  11. Mao J., Duan R. W., Zhong L., Gibori G., Azhar S. Expression, purification and characterization of the rat luteal 20 alpha-hydroxysteroid dehydrogenase. Endocrinology. 1997 Jan;138(1):182–190. doi: 10.1210/endo.138.1.4825. [DOI] [PubMed] [Google Scholar]
  12. Mao J., Duan W. R., Albarracin C. T., Parmer T. G., Gibori G. Isolation and characterization of a rat luteal cDNA encoding 20 alpha-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1289–1295. doi: 10.1006/bbrc.1994.1844. [DOI] [PubMed] [Google Scholar]
  13. Miller W. L., Auchus R. J., Geller D. H. The regulation of 17,20 lyase activity. Steroids. 1997 Jan;62(1):133–142. doi: 10.1016/s0039-128x(96)00172-9. [DOI] [PubMed] [Google Scholar]
  14. Miura R., Shiota K., Noda K., Yagi S., Ogawa T., Takahashi M. Molecular cloning of cDNA for rat ovarian 20 alpha-hydroxysteroid dehydrogenase (HSD1). Biochem J. 1994 Apr 15;299(Pt 2):561–567. doi: 10.1042/bj2990561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mori M., Wiest W. G. Purification of rat ovary 20 alpha-hydroxysteroid dehydrogenase by affinity chromatography. J Steroid Biochem. 1979 Oct;11(4):1443–1449. doi: 10.1016/0022-4731(79)90119-5. [DOI] [PubMed] [Google Scholar]
  16. Nakajin S., Hall P. F. Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase). J Biol Chem. 1981 Apr 25;256(8):3871–3876. [PubMed] [Google Scholar]
  17. Noda K., Shiota K., Takahashi M. Purification and characterization of rat ovarian 20 alpha-hydroxysteroid dehydrogenase. Biochim Biophys Acta. 1991 Aug 9;1079(1):112–118. doi: 10.1016/0167-4838(91)90031-t. [DOI] [PubMed] [Google Scholar]
  18. Pawlowski J. E., Penning T. M. Overexpression and mutagenesis of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. J Biol Chem. 1994 May 6;269(18):13502–13510. [PubMed] [Google Scholar]
  19. Penning T. M., Mukharji I., Barrows S., Talalay P. Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem J. 1984 Sep 15;222(3):601–611. doi: 10.1042/bj2220601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Penning T. M., Sharp R. B. Prostaglandin dehydrogenase activity of purified rat liver 3 alpha-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun. 1987 Oct 29;148(2):646–652. doi: 10.1016/0006-291x(87)90925-9. [DOI] [PubMed] [Google Scholar]
  21. Penning T. M., Talalay P. Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4504–4508. doi: 10.1073/pnas.80.14.4504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Petrash J. M., Harter T. M., Murdock G. L. A potential role for aldose reductase in steroid metabolism. Adv Exp Med Biol. 1997;414:465–473. doi: 10.1007/978-1-4615-5871-2_53. [DOI] [PubMed] [Google Scholar]
  23. Pongsawasdi P., Anderson B. M. Kinetic studies of rat ovarian 20 alpha-hydroxysteroid dehydrogenase. Biochim Biophys Acta. 1984 May 25;799(1):51–58. doi: 10.1016/0304-4165(84)90326-x. [DOI] [PubMed] [Google Scholar]
  24. Smith S. S., Gong Q. H., Hsu F. C., Markowitz R. S., ffrench-Mullen J. M., Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998 Apr 30;392(6679):926–930. doi: 10.1038/31948. [DOI] [PubMed] [Google Scholar]
  25. Tanaka N. M., Shiota K., Noda K., Kadosawa T., Mochizuki M., Nishimura R., Takahashi M., Sasaki N. Effects of 20 alpha-hydroxysteroid dehydrogenase and its inhibitors on canine osteosarcoma cell growth in vitro. J Vet Med Sci. 1996 Jul;58(7):623–627. doi: 10.1292/jvms.58.623. [DOI] [PubMed] [Google Scholar]
  26. Valavaara R. Reliability of estrogen receptors in predicting response to antiestrogens. Oncology (Williston Park) 1997 May;11(5 Suppl 4):14–18. [PubMed] [Google Scholar]
  27. WIEST W. G., FORBES T. R. FAILURE OF 20 ALPHA-HYDROXY-DELTA-4-PREGNEN-3-ONE AND 20-BETA-HYDROXY-DELTA-4-PREGNEN-3-ONE TO MAINTAIN PREGNANCY IN OVARIECTOMIZED MICE. Endocrinology. 1964 Jan;74:149–150. doi: 10.1210/endo-74-1-149. [DOI] [PubMed] [Google Scholar]
  28. WIEST W. G., WILCOX R. B. Purification and properties of rat ovarian 20 alpha-hydroxysteroid dehydrogenase. J Biol Chem. 1961 Sep;236:2425–2428. [PubMed] [Google Scholar]
  29. WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Warren J. C., Murdock G. L., Ma Y., Goodman S. R., Zimmer W. E. Molecular cloning of testicular 20 alpha-hydroxysteroid dehydrogenase: identity with aldose reductase. Biochemistry. 1993 Feb 16;32(6):1401–1406. doi: 10.1021/bi00057a003. [DOI] [PubMed] [Google Scholar]
  31. Wermuth B., Monder C. Aldose and aldehyde reductase exhibit isocorticosteroid reductase activity. Eur J Biochem. 1983 Mar 15;131(2):423–426. doi: 10.1111/j.1432-1033.1983.tb07280.x. [DOI] [PubMed] [Google Scholar]
  32. Wiest W. G., Kidwell W. R., Balogh K., Jr Progesterone catabolism in the rat ovary: a regulatory mechanism for progestational potency during pregnancy. Endocrinology. 1968 Apr;82(4):844–859. doi: 10.1210/endo-82-4-844. [DOI] [PubMed] [Google Scholar]
  33. Wilson D. K., Tarle I., Petrash J. M., Quiocho F. A. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9847–9851. doi: 10.1073/pnas.90.21.9847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wintergalen N., Thole H. H., Galla H. J., Schlegel W. Prostaglandin-E2 9-reductase from corpus luteum of pseudopregnant rabbit is a member of the aldo-keto reductase superfamily featuring 20 alpha-hydroxysteroid dehydrogenase activity. Eur J Biochem. 1995 Nov 15;234(1):264–270. doi: 10.1111/j.1432-1033.1995.264_c.x. [DOI] [PubMed] [Google Scholar]
  35. Zhong L., Ou J., Barkai U., Mao J. F., Frasor J., Gibori G. Molecular cloning and characterization of the rat ovarian 20 alpha-hydroxysteroid dehydrogenase gene. Biochem Biophys Res Commun. 1998 Aug 28;249(3):797–803. doi: 10.1006/bbrc.1998.9229. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES